BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37170966)

  • 21. Current profile of Charcot-Marie-Tooth disease in Africa: A systematic review.
    Yalcouyé A; Esoh K; Guida L; Wonkam A
    J Peripher Nerv Syst; 2022 Jun; 27(2):100-112. PubMed ID: 35383421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing.
    Murphy SM; Laura M; Fawcett K; Pandraud A; Liu YT; Davidson GL; Rossor AM; Polke JM; Castleman V; Manji H; Lunn MP; Bull K; Ramdharry G; Davis M; Blake JC; Houlden H; Reilly MM
    J Neurol Neurosurg Psychiatry; 2012 Jul; 83(7):706-10. PubMed ID: 22577229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic yield of targeted sequential and massive panel approaches for inherited neuropathies.
    Padilha JPD; Brasil CS; Hoefel AML; Winckler PB; Donis KC; Brusius-Facchin AC; Saute JAM
    Clin Genet; 2020 Aug; 98(2):185-190. PubMed ID: 32506583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Guidelines for molecular diagnosis of Charcot-Marie-Tooth disease].
    Berciano J; Sevilla T; Casasnovas C; Sivera R; Vílchez JJ; Infante J; Ramón C; Pelayo-Negro AL; Illa I;
    Neurologia; 2012 Apr; 27(3):169-78. PubMed ID: 21703725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic spectrum and clinical profiles in a southeast Chinese cohort of Charcot-Marie-Tooth disease.
    Chen CX; Dong HL; Wei Q; Li LX; Yu H; Li JQ; Liu GL; Li HF; Bai G; Ma H; Wu ZY
    Clin Genet; 2019 Nov; 96(5):439-448. PubMed ID: 31372974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotype of Charcot-Marie-Tooth disease Type 2.
    Bienfait HM; Baas F; Koelman JH; de Haan RJ; van Engelen BG; Gabreëls-Festen AA; Ongerboer de Visser BW; Meggouh F; Weterman MA; De Jonghe P; Timmerman V; de Visser M
    Neurology; 2007 May; 68(20):1658-67. PubMed ID: 17502546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.
    Berciano J; García A; Gallardo E; Peeters K; Pelayo-Negro AL; Álvarez-Paradelo S; Gazulla J; Martínez-Tames M; Infante J; Jordanova A
    J Neurol; 2017 Aug; 264(8):1655-1677. PubMed ID: 28364294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compound heterozygous mutations of SH3TC2 in Charcot-Marie-Tooth disease type 4C patients.
    Lee AJ; Nam SH; Park JM; Kanwal S; Choi YJ; Lee HJ; Lee KS; Lee JE; Park JS; Choi BO; Chung KW
    J Hum Genet; 2019 Sep; 64(9):961-965. PubMed ID: 31227790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutational screening of the SH3TC2 gene in Greek patients with suspected demyelinating recessive Charcot-Marie-Tooth disease reveals a varied and unusual phenotypic spectrum.
    Kontogeorgiou Z; Nikolaou K; Kartanou C; Breza M; Panas M; Karadima G; Koutsis G
    J Peripher Nerv Syst; 2019 Mar; 24(1):125-130. PubMed ID: 30653784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GDAP1 mutations in Italian axonal Charcot-Marie-Tooth patients: Phenotypic features and clinical course.
    Pezzini I; Geroldi A; Capponi S; Gulli R; Schenone A; Grandis M; Doria-Lamba L; La Piana C; Cremonte M; Pisciotta C; Nolano M; Manganelli F; Santoro L; Mandich P; Bellone E
    Neuromuscul Disord; 2016 Jan; 26(1):26-32. PubMed ID: 26525999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and genetic diversities of Charcot-Marie-Tooth disease with MFN2 mutations in a large case study.
    Ando M; Hashiguchi A; Okamoto Y; Yoshimura A; Hiramatsu Y; Yuan J; Higuchi Y; Mitsui J; Ishiura H; Umemura A; Maruyama K; Matsushige T; Morishita S; Nakagawa M; Tsuji S; Takashima H
    J Peripher Nerv Syst; 2017 Sep; 22(3):191-199. PubMed ID: 28660751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted next-generation sequencing panels in the diagnosis of Charcot-Marie-Tooth disease.
    Cortese A; Wilcox JE; Polke JM; Poh R; Skorupinska M; Rossor AM; Laura M; Tomaselli PJ; Houlden H; Shy ME; Reilly MM
    Neurology; 2020 Jan; 94(1):e51-e61. PubMed ID: 31827005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MFN2 point mutations occur in 3.4% of Charcot-Marie-Tooth families. An investigation of 232 Norwegian CMT families.
    Braathen GJ; Sand JC; Lobato A; Høyer H; Russell MB
    BMC Med Genet; 2010 Mar; 11():48. PubMed ID: 20350294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of the Italian version of the Charcot-Marie-Tooth Health Index.
    Pisciotta C; Ciafaloni E; Zuccarino R; Calabrese D; Saveri P; Fenu S; Tramacere I; Genovese F; Dilek N; Johnson NE; Heatwole C; Herrmann DN; Pareyson D;
    J Peripher Nerv Syst; 2020 Sep; 25(3):292-296. PubMed ID: 32511835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene.
    Sanmaneechai O; Feely S; Scherer SS; Herrmann DN; Burns J; Muntoni F; Li J; Siskind CE; Day JW; Laura M; Sumner CJ; Lloyd TE; Ramchandren S; Shy RR; Grider T; Bacon C; Finkel RS; Yum SW; Moroni I; Piscosquito G; Pareyson D; Reilly MM; Shy ME;
    Brain; 2015 Nov; 138(Pt 11):3180-92. PubMed ID: 26310628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autosomal recessive Charcot-Marie-Tooth disease: from genes to phenotypes.
    Tazir M; Bellatache M; Nouioua S; Vallat JM
    J Peripher Nerv Syst; 2013 Jun; 18(2):113-29. PubMed ID: 23781959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular analysis in Japanese patients with Charcot-Marie-Tooth disease: DGGE analysis for PMP22, MPZ, and Cx32/GJB1 mutations.
    Numakura C; Lin C; Ikegami T; Guldberg P; Hayasaka K
    Hum Mutat; 2002 Nov; 20(5):392-8. PubMed ID: 12402337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and genetic spectra in a series of Chinese patients with Charcot-Marie-Tooth disease.
    Wang R; He J; Li JJ; Ni W; Wu ZY; Chen WJ; Wang Y
    Clin Chim Acta; 2015 Dec; 451(Pt B):263-70. PubMed ID: 26454100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Charcot-Marie-Tooth type 2 and distal hereditary motor neuropathy: Clinical, neurophysiological and genetic findings from a single-centre experience.
    Luigetti M; Fabrizi GM; Bisogni G; Romano A; Taioli F; Ferrarini M; Bernardo D; Rossini PM; Sabatelli M
    Clin Neurol Neurosurg; 2016 May; 144():67-71. PubMed ID: 26989944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic epidemiology of Charcot-Marie-Tooth in the general population.
    Braathen GJ; Sand JC; Lobato A; Høyer H; Russell MB
    Eur J Neurol; 2011 Jan; 18(1):39-48. PubMed ID: 20482598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.